Human Acetylator Polymorphism: Estimate of Allele Frequency in Libya and Details of Global Distribution

Overview

Journal J Med Genet

Specialty Genetics

Date 1981 Oct 1

PMID 7328611

Citations 15

Authors

A K Karim

M S Elfellah

D A Evans

Affiliations

Soon will be listed here.

Abstract

Acetylator phenotyping by means of a sulphadimidine tests revealed 65% of Libyan Arabs to be slow acetylators. Hence the frequency of the allele controlling slow acetylation (As) is estimated as q = 0.81 +/- 0.05. This estimate is similar to those previously recorded in European and adjacent Middle Eastern populations.

Citing Articles

Dapsone, More than an Effective Neuro and Cytoprotective Drug.

Diaz-Ruiz A, Nader-Kawachi J, Calderon-Estrella F, Mata-Bermudez A, Alvarez-Mejia L, Rios C Curr Neuropharmacol. 2021; 20(1):194-210.

PMID: 34139984 PMC: 9199557. DOI: 10.2174/1570159X19666210617143108.

Isoniazid acetylation phenotypes in the Sudanese population; findings and implications.

Ali M, Alrasheedy A, Kibuule D, Hassali M, Godman B, Abdelwahab M J Clin Tuberc Other Mycobact Dis. 2019; 17:100120.

PMID: 31788562 PMC: 6879993. DOI: 10.1016/j.jctube.2019.100120.

Deciphering the ancient and complex evolutionary history of human arylamine N-acetyltransferase genes.

Patin E, Barreiro L, Sabeti P, Austerlitz F, Luca F, Sajantila A Am J Hum Genet. 2006; 78(3):423-36.

PMID: 16416399 PMC: 1380286. DOI: 10.1086/500614.

Slow acetylator mutations in the human polymorphic N-acetyltransferase gene in 786 Asians, blacks, Hispanics, and whites: application to metabolic epidemiology.

Lin H, Han C, Lin B, Hardy S Am J Hum Genet. 1993; 52(4):827-34.

PMID: 8460648 PMC: 1682080.

Acetylator phenotypes in Papua New Guinea.

Penketh R, Gibney S, Nurse G, Hopkinson D J Med Genet. 1983; 20(1):37-40.

PMID: 6842533 PMC: 1048983. DOI: 10.1136/jmg.20.1.37.

References

Frislid K, Berg M, Hansteen V, Lunde P . Comparison of the acetylation of procainamide and sulfadimidine in man. Eur J Clin Pharmacol. 1976; 09(5-6):433-8. DOI: 10.1007/BF00606561. View

SUNAHARA S, Urano M, Lin H, CHEG T, JARUMILINDA A . FURTHER OBSERVATIONS ON TRIMODALITY OF FREQUENCY DISTRIBUTION CURVE OF BIOLOGICALLY ACTIVE ISONIAZID BLOOD LEVELS AND "CLINE" INFREQUENCIES OF ALLELES CONTROLLING ISONIAZID INACTIVATION. Acta Tuberc Pneumol Scand. 1963; 43:181-95. View

SUNAHARA S, Urano M . [PROBLEMS OF ISONIAZID METABOLISM. HEREDITARY CHARACTER AND VARIABILITY ACCORDING TO RACES]. Med Thorac. 1963; 20:289-312. View

Dufour A, Knight R, Harris H . GENETICS OF ISONIAZID METABOLISM IN CAUCASIAN, NEGRO, AND JAPANESE POPULATIONS. Science. 1964; 145(3630):391. View

Mattila M, Tiitinen H . The rate of isoniazid inactivation in Finnish diabetic and non-diabetic patients. Ann Med Exp Biol Fenn. 1967; 45(4):423-7. View

Eze L, Obidoa O . Acetylation of sulfamethazine in a Nigerian population. Biochem Genet. 1978; 16(11-12):1073-7. DOI: 10.1007/BF00484527. View

Rao K, Mitchison D, Nair N, Prema K, Tripathy S . Sulphadimidine acetylation test for classification of patients as slow or rapid inactivators of isoniazid. Br Med J. 1970; 3(5721):495-7. PMC: 1701336. DOI: 10.1136/bmj.3.5721.495. View

Lehir M, CHICOU J, HETRICK G, Mercier A, NEEL R, RIST N . [CLINICAL TRIAL OF 3 TYPES OF ORAL TREATMENT OF PULMONARY TUBERCULOSIS. (ISONIAZID+ETHIONAMIDE, ISONIAZID + PAS, ISONIAZID ALONE)]. Bull World Health Organ. 1964; 30:701-32. PMC: 2554981. View

Hanngren A, Borga O, Sjoqvist F . Inactivation of isoniazid (INH) in Swedish tuberculous patients before and during treatment with para-aminosalicylic acid (PAS). Scand J Respir Dis. 1970; 51(1):61-9. View

10.

Evans D, Bullen M, Houston J, Hopkins C, Vetters J . Antinuclear factor in rapid and slow acetylator patients treated with isoniazid. J Med Genet. 1972; 9(1):53-6. PMC: 1469207. DOI: 10.1136/jmg.9.1.53. View

11.

Hodgkin M, EIDUS L, Bailey W . Isoniazid phenotyping of black as well as white patients. Can J Physiol Pharmacol. 1979; 57(7):760-3. DOI: 10.1139/y79-117. View

12.

VIZNEROVA A, Slavikova Z, Ellard G . The determination of the acetylator phenotype of tuberculosis patients in Czechoslovakia using sulphadimidine. Tubercle. 1973; 54(1):67-71. DOI: 10.1016/0041-3879(73)90016-0. View

13.

Hoo J, Hussein L, GOEDDE H . A simplified micromethod for the determination of the acetylator phenotype. J Clin Chem Clin Biochem. 1977; 15(6):329-31. DOI: 10.1515/cclm.1977.15.1-12.329. View

14.

Smith S, Kyi T . Inactivation of isoniazid in Burmese subjects. Nature. 1968; 217(5135):1273. DOI: 10.1038/2171273a0. View

15.

Tiitinen H . Isoniazid and ethionamide serum levels and inactivation in Finnish subjects. Scand J Respir Dis. 1969; 50(2):110-24. View

16.

Schroder H, Evans D . Acetylator phenotype and adverse effects of sulphasalazine in healthy subjects. Gut. 1972; 13(4):278-84. PMC: 1412167. DOI: 10.1136/gut.13.4.278. View

17.

EIDUS L, Hodgkin M, Schaefer O, Jessamine A . Distribution of isoniazid inactivators determined in Eskimos and Canadian college students by a urine test. Rev Can Biol. 1974; 33(2):117-23. View

18.

Peters J, Gordon G, Ghoul D, TOLENTINO J, Walsh G, Levy L . The diposition of the antileprotic drug dapsone (DDS) in Philippine subjects. Am J Trop Med Hyg. 1972; 21(4):450-7. DOI: 10.4269/ajtmh.1972.21.450. View

19.

DEVADATTA S, GANGADHARAM P, Andrews R, Fox W, Ramakrishnan C, Selkon J . Peripheral neuritis due to isoniazid. Bull World Health Organ. 1960; 23:587-98. PMC: 2555613. View

20.

Jenkins T, Lehmann H, Nurse G . Public health and genetic constitution of the San ("Bushmen"): carbohydrate metabolism and acetylator status of the Kung of Tsumkwe in the North-western Kalahari. Br Med J. 1974; 2(5909):23-6. PMC: 1610132. DOI: 10.1136/bmj.2.5909.23. View